Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xun C, Zhou"'
Autor:
Russell J, Schilder, William E, Brady, Heather A, Lankes, James V, Fiorica, Mark S, Shahin, Xun C, Zhou, Robert S, Mannel, Harsh B, Pathak, Wei, Hu, R Katherine, Alpaugh, Anil K, Sood, Andrew K, Godwin
Publikováno v:
Gynecologic Oncology. 127:70-74
Preclinical data suggest an important role for the sarcoma proto-oncogene tyrosine kinase (SRC) in the oncogenesis of epithelial ovarian cancer (EOC) or primary peritoneal carcinoma (PPC). The Gynecologic Oncology Group (GOG) conducted a Phase II tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edce07d9adadf2af8b6ac97f10784a6
https://doi.org/10.1016/j.ygyno.2012.06.009
https://doi.org/10.1016/j.ygyno.2012.06.009
Autor:
Linda Van Le, Parviz Hanjani, Heather A. Lankes, Xun C. Zhou, Anil K. Sood, Wei Hu, Lisa M. Landrum, Carol Aghajanian, Debra L. Richardson, Angeles Alvarez Secord, Michael E. Carney, Siobhan M. Kehoe, Robert L. Coleman, Michael W. Sill, Michael L. Pearl, Heidi J. Gray
Publikováno v:
JAMA Oncology. 4:196
Importance Ovarian cancer is the leading cause of gynecologic cancer deaths in the United States. Pazopanib is an oral, multitarget kinase inhibitor of vascular endothelial growth factor receptors 1, 2, and 3; platelet-derived growth factor receptors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b70137329a2816d07bd5bce6c59e7b97
https://doi.org/10.1001/jamaoncol.2017.4218
https://doi.org/10.1001/jamaoncol.2017.4218
Autor:
Loyd A. West, Tracilyn Hall, John O. Schorge, Cheung Wong, Xun C. Zhou, Amy Bregar, Christopher J. Darus, Rosemary Foster
Publikováno v:
Gynecology & Obstetrics.
Ovarian cancer accounts for more deaths in the United States than all other gynecologic malignancies combined. More than two-thirds of patients are still diagnosed, as they always have been, with advanced stage disease. Traditionally, upfront surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84f5b32321ae4ff7a5ebcd5875cb7921
https://doi.org/10.4172/2161-0932.1000289
https://doi.org/10.4172/2161-0932.1000289
Autor:
Xun C. Zhou, James E. Kendrick, Jeanne M. Schilder, Joan L. Walker, Charles R. Harrison, Carol Aghajanian, Edwin A. Alvarez, S. Diane Yamada, Jacob Rotmensch, David E. Cohn, Kathleen N. Moore, William E. Brady
Publikováno v:
Gynecologic oncology. 129(1)
Objective This two-stage phase II study was designed to assess the activity of the combination of temsirolimus and bevacizumab in patients with recurrent or persistent endometrial carcinoma (EMC). Methods Eligible patients had persistent or recurrent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::013e090af648fc984040072a2d4e75d7
https://pubmed.ncbi.nlm.nih.gov/23262204
https://pubmed.ncbi.nlm.nih.gov/23262204
Autor:
Gerald S. Falchook, Robert L. Coleman, Lainie P. Martin, Barbara A. Goff, Razelle Kurzrock, H. Xiao, Russell J. Schilder, Xun C. Zhou, Ely Benaim, Heidi J. Gray
Publikováno v:
Gynecologic Oncology. 125:S31-S32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcaf66ad05b0ad7e4361de2e70512146
https://doi.org/10.1016/j.ygyno.2011.12.071
https://doi.org/10.1016/j.ygyno.2011.12.071